These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23504369)

  • 1. Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.
    Shi B; Abrams M
    J Histochem Cytochem; 2013 Jun; 61(6):407-20. PubMed ID: 23504369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.
    Shi B; Keough E; Matter A; Leander K; Young S; Carlini E; Sachs AB; Tao W; Abrams M; Howell B; Sepp-Lorenzino L
    J Histochem Cytochem; 2011 Aug; 59(8):727-40. PubMed ID: 21804077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey.
    Sarisozen C; Salzano G; Torchilin VP
    Curr Pharm Biotechnol; 2016; 17(8):728-40. PubMed ID: 27033509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
    Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
    Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and metabolism studies of lipid nanoparticle-formulated internally [3H]-labeled siRNA in mice.
    Christensen J; Litherland K; Faller T; van de Kerkhof E; Natt F; Hunziker J; Boos J; Beuvink I; Bowman K; Baryza J; Beverly M; Vargeese C; Heudi O; Stoeckli M; Krauser J; Swart P
    Drug Metab Dispos; 2014 Mar; 42(3):431-40. PubMed ID: 24389421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.
    Yu B; Wang X; Zhou C; Teng L; Ren W; Yang Z; Shih CH; Wang T; Lee RJ; Tang S; Lee LJ
    Pharm Res; 2014 Oct; 31(10):2685-95. PubMed ID: 24740244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity.
    Pittella F; Zhang M; Lee Y; Kim HJ; Tockary T; Osada K; Ishii T; Miyata K; Nishiyama N; Kataoka K
    Biomaterials; 2011 Apr; 32(11):3106-14. PubMed ID: 21272932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanotherapeutics for siRNA delivery.
    Schroeder A; Levins CG; Cortez C; Langer R; Anderson DG
    J Intern Med; 2010 Jan; 267(1):9-21. PubMed ID: 20059641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA.
    Wang H; Tam YY; Chen S; Zaifman J; van der Meel R; Ciufolini MA; Cullis PR
    Mol Ther; 2016 Dec; 24(12):2100-2108. PubMed ID: 27633442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of palmitic acid improves potency and longevity of siRNA delivered via endosomolytic polymer nanoparticles.
    Sarett SM; Kilchrist KV; Miteva M; Duvall CL
    J Biomed Mater Res A; 2015 Sep; 103(9):3107-16. PubMed ID: 25641816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.